Filing Details

Accession Number:
0001209191-23-023006
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-04-04 19:15:37
Reporting Period:
2023-04-01
Accepted Time:
2023-04-04 19:15:37
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1818331 Genedx Holdings Corp. WGS Services-Health Services (8000) 851966622
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1873805 Kareem Saad C/O Genedx Holdings Corp.
333 Ludlow St, North Tower, 6Th Fl.
Stamford CT 06902
Chief Transformation Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Class A Common Stock Acquisiton 2023-04-01 9,005 $0.00 187,435 No 4 M Direct
Class A Common Stock Disposition 2023-04-03 2,776 $0.34 184,659 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Class A Common Stock Restricted Stock Unit Disposition 2023-04-01 9,005 $0.00 9,005 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
108,066 No 4 M Direct
Footnotes
  1. Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration.
  2. The sales reported on this Form 4 represent shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sales were to satisfy tax withholding obligations to be funded by a "sell to cover" transaction.
  3. The price reported in Column 4 is a weighted average price. These shares were sold as part of a block trade for multiple transactions at prices ranging from $0.3266 to $0.36, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.
  4. 6.25% vest in quarterly installments over the 4-year period on April 4, 2022 until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date